SCHEMBL10062819

SCHEMBL10062819

N#Cc1ccc(C(=O)Nc2cc(-c3ccncc3)c[nH]c2=O)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITK Q08881 11/20 0.73
TTK P33981 5/20 0.72
AURKB Q96GD4 4/20 0.72
INCENP Q9NQS7 4/20 0.72
AURKA O14965 3/20 0.72
KIT P10721 4/20 0.70
SRC P12931 4/20 0.70
FLT3 P36888 4/20 0.70
GPR142 Q7Z601 4/20 0.65
PIK3CD O00329 1/20 0.52
PIK3CA P42336 1/20 0.52
PIK3CB P42338 1/20 0.52
GAK O14976 1/20 0.48
STK16 O75716 1/20 0.48
PIM1 P11309 1/20 0.48
AXL P30530 1/20 0.48
NEK2 P51955 1/20 0.48
STK3 Q13188 1/20 0.48
STK11 Q15831 1/20 0.48
AAK1 Q2M2I8 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10062850 0.88 ITK (0.71) ITKTTKAURKBINCENPAURKA
SCHEMBL10062864 0.85 ITK (0.80) ITKTTKAURKBINCENPAURKA
SCHEMBL10062828 0.84 ITK (0.90) ITKTTKAURKBINCENPAURKA
SCHEMBL15850208 0.84 ITK (0.78) ITKTTKAURKBINCENPAURKA
SCHEMBL10062837 0.84 ITK (0.78) ITKTTKAURKBINCENPAURKA
SCHEMBL15850092 0.84 ITK (0.78) ITKTTKAURKBINCENPAURKA
SCHEMBL5241521 0.84 ITK (0.78) ITKTTKAURKBINCENPAURKA
SCHEMBL10062820 0.84 ITK (1.00) ITKTTKAURKBINCENPAURKA
SCHEMBL10062852 0.84 ITK (0.78) ITKTTKAURKBINCENPAURKA
SCHEMBL10062920 0.84 ITK (0.71) ITKTTKAURKBINCENPAURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130184259-A1 PYRIDONES USEFUL AS INHIBITORS OF KINASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-07-18 US disclosed
US-20130184259-A1 PYRIDONES USEFUL AS INHIBITORS OF KINASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-07-18 US disclosed
US-8338597-B2 Pyridones useful as inhibitors of kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-12-25 US disclosed
US-8338597-B2 Pyridones useful as inhibitors of kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-12-25 US disclosed
US-20120190699-A1 PYRIDONES USEFUL AS INHIBITORS OF KINASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-07-26 US disclosed
US-20120190699-A1 PYRIDONES USEFUL AS INHIBITORS OF KINASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-07-26 US disclosed
US-8101770-B2 Pyridones useful as inhibitors of kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-01-24 US disclosed
US-8101770-B2 Pyridones useful as inhibitors of kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-01-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120190699-A1 PYRIDONES USEFUL AS INHIBITORS OF KINASES MAP3K20, MAP3K6, MAP3K5 ITK 393/4885TTK 242/4885AURKB 167/4885
US-20130184259-A1 PYRIDONES USEFUL AS INHIBITORS OF KINASES MAP3K20, MAP3K6, MAP3K5 ITK 393/4885TTK 242/4885AURKB 167/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.